Skip to content

Insider · CIK 0002005875

Alexandra Hughes-Wilson

officer

Files at MREO (Mereo BioPharma Group plc). First filing -, latest -.

In brief

Alexandra Hughes-Wilson files SEC Form 4 as officer at MREO (Mereo BioPharma Group plc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Alexandra Hughes-Wilson has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 4 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 1, 2026MREO
Mereo BioPharma Group plc
AGrant or award
Share Options (Right to buy)derivative
+183,750$0.00$0183,750Feb 2, 2026
Feb 1, 2026MREO
Mereo BioPharma Group plc
AGrant or award
Share Options (Right to buy)derivative
+61,250$0.00$061,250Feb 2, 2026
Feb 1, 2026MREO
Mereo BioPharma Group plc
AGrant or award
Share Options (Right to buy)derivative
+195,000$0.00$0195,000Feb 2, 2026
Jan 25, 2025MREO
Mereo BioPharma Group plc
AGrant or award
Share Options (Right to buy)derivative
+154,000$0.00$0154,000Jan 28, 2025

Questions about Alexandra Hughes-Wilson

Answered from the filings on this page, as of the latest one.

Is Alexandra Hughes-Wilson buying or selling?

Alexandra Hughes-Wilson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Alexandra Hughes-Wilson's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alexandra Hughes-Wilson has 0.

Where does Alexandra Hughes-Wilson file Form 4?

Alexandra Hughes-Wilson has filed Form 4 at MREO (Mereo BioPharma Group plc) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Alexandra Hughes-Wilson: insider trades and track record | InsiderTell